Happy Saturday, team. After five long days of whisky-tasting, watch releases and new car launches, the second week of November has triumphantly drawn to a close. Make no mistake, the silly season is ...
With a bunch of gene therapy and gene editing programs in clinical trials, CRISPR Therapeutics (NASDAQ: CRSP) has an impressive resume already, but it's just getting started. It's currently in the ...